Home › Multiple Myeloma › North Carolina

Pag-aaral pangklinika para sa Multiple Myeloma sa North Carolina

53 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Novant Health Cancer Institute, Charlotte
Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07555938

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

University of North Carolina /ID# 251203, Chapel Hill
Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

University of North Carolina at Chapel Hill, Chapel Hill
Wake Forest University Health Sciences, Winston-Salem

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05137054

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Levine Cancer Institute, Charlotte

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05201781

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07149857

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Levine Cancer Institute, Charlotte
Novant Health, Charlotte
Durham VAMC, Durham
at 3 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05552222

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Levine Cancer Institute, Charlotte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05652335

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

University of North Carolina, Chapel Hill
Durham VAMC, Durham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07258511

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

University of North Carolina Hospitals at Hillsborough, Chapel Hill

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433947

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

UNC Hospitals Adult Oncology Clinics, Chapel Hill

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07284758

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Duke Cancer Center, Durham

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07280013

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06615479

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
University Of North Carolina Health Care - Hillsborough Campus /ID# 272454, Hillsborough
Atrium Health Wake Forest Baptist Medical Center /ID# 271294, Winston-Salem

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06953960

Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma

Levine Cancer Institute, Charlotte
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT04822337

Neurocognitive Trajectories After BCMA CAR-T

Atrium Health Levine Cancer, Charlotte

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07740317

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Atrium Health, Levine Cancer Institute, Charlotte
Duke University Hospital, Durham

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT05651932

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem

Nagre-recruitPhase 2

Edad 60 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06052826

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

Research Site, Chapel Hill
Research Site, Charlotte
Research Site, Durham
at 1 pa

Nagre-recruitPhase 3

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07735637

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill
Atrium Health Levine Cancer Institute /ID# 276193, Charlotte
Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06892522

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

University of North Carolina at Chapel Hill /ID# 277708, Chapel Hill

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07095452

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Duke University, Durham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07648264

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Research Site, Charlotte
Research Site, Durham

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT05850234

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

University of North Carolina Medical Center, Chapel Hill

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06297226

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Research Site, Chapel Hill
Research Site, Charlotte
Research Site, Charlotte
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07391657

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Duke University Medical Center, Durham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07518186

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Duke University Medical Center, Durham

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06500884

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Atrium Health Levine Cancer Institute, Charlotte

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lineberger Comprehensive Cancer Center, Chapel Hill
Atrium Health's Levine Cancer Institute, Charlotte

Nagre-recruitPhase 2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM

Duke University Health System, Durham

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06822972

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

University of North Carolina Hospitals at Hillsborough, Hillsborough

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06375044

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04566328

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

GSK Investigational Site, Chapel Hill
GSK Investigational Site, Wilson

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05714839

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill

Nagre-recruit

Edad 60 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06296368

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Research Site, Chapel Hill
Research Site, Charlotte
Research Site, Durham
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07764978

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Duke Institute of Cancer/ Duke University, Durham

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT02343042

Pre-malignant States to Hematologic Malignancies in Firefighters

Levine Cancer Institute, Charlotte

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 49 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06870760

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Atrium Health Levine Cancer, Charlotte

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 30 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06644625

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

University of North Carolina (Data Collection Only), Chapel Hill

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06083922

Registry of Older Patients With Cancer

Seby B. Jones Cancer Center, Boone
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
East Carolina University, Greenville
at 4 pa

Nagre-recruitObservasyonal na pag-aaral

Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.